C07D 237/10
With hetero atoms or with carbon atoms having three bonds to hetero
Official title: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
C07D237/10 (With hetero atoms or with carbon atoms having three bonds to hetero) appears on 1,243 US grants and 1,174 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,243
- Published applications
- 1,174
- Assignees
- 579
- Inventors
- 4,626
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 9 | 0 |
| 1978 | 16 | 0 |
| 1979 | 8 | 0 |
| 1980 | 10 | 0 |
| 1981 | 17 | 0 |
| 1982 | 16 | 0 |
| 1983 | 8 | 0 |
| 1984 | 12 | 0 |
| 1985 | 12 | 0 |
| 1986 | 24 | 0 |
| 1987 | 24 | 0 |
| 1988 | 16 | 0 |
| 1989 | 30 | 0 |
| 1990 | 28 | 0 |
| 1991 | 33 | 0 |
| 1992 | 24 | 0 |
| 1993 | 17 | 0 |
| 1994 | 18 | 0 |
| 1995 | 18 | 0 |
| 1996 | 14 | 0 |
| 1997 | 23 | 0 |
| 1998 | 24 | 0 |
| 1999 | 23 | 0 |
| 2000 | 16 | 0 |
| 2001 | 20 | 4 |
| 2002 | 21 | 15 |
| 2003 | 16 | 33 |
| 2004 | 14 | 48 |
| 2005 | 15 | 56 |
| 2006 | 20 | 38 |
| 2007 | 33 | 31 |
| 2008 | 27 | 48 |
| 2009 | 30 | 55 |
| 2010 | 29 | 60 |
| 2011 | 26 | 50 |
| 2012 | 37 | 38 |
| 2013 | 35 | 51 |
| 2014 | 35 | 53 |
| 2015 | 63 | 56 |
| 2016 | 44 | 46 |
| 2017 | 58 | 62 |
| 2018 | 44 | 44 |
| 2019 | 34 | 40 |
| 2020 | 34 | 50 |
| 2021 | 32 | 47 |
| 2022 | 29 | 47 |
| 2023 | 24 | 62 |
| 2024 | 16 | 58 |
| 2025 | 29 | 49 |
| 2026 | 30 | 33 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- N2-arylmethyl-4-haloalkyl-pyridazin-3-one CFTR modulators for the treatment of cystic fibrosis29 Sep 2026US 12,747,215 B2Centre National de la Recherche Scientifique (CNRS)
- EAAT2 activators and methods of using thereof29 Sep 2026US 12,747,227 B2Ohio State Innovation Foundation
- Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents22 Sep 2026US 12,740,943 B2ModernaTX, Inc.
- Substituted pyridazine compound22 Sep 2026US 12,741,942 B2Tenvie Therapeutics, Inc.
- Heterocyclic compound1 Sep 2026US 12,723,028 B2Takeda Pharmaceutical Company Limited
- Method for Treating Phosphorus-Containing Wastewater Produced During Preparation of Sulfonamide Compound8 Oct 2026US 2026/0308035 A1Nanhai Beisha Pharmaceutical Co., Ltd.
- Compound as voltage-gated sodium channel inhibitor3 Sep 2026US 2026/0257996 A1Guangzhou Fermion Technology Co., Ltd.
- Process for the preparation of (6s,9r)-3-oxo-3,5,6,7,8,9-hexahydro-2h-6,9-epiminocyclohepta[c]pyridazine-10-carboxamide derivatives3 Sep 2026US 2026/0258043 A1Pathios Therapeutics Limited
- Method for preparing pyridine oxynitride compound20 Aug 2026US 2026/0242339 A1Shanghai Jemincare Pharmaceutical Co., Ltd.
- Nav 1.7 and/or nav 1.8 blocking hydrazides, processes for the preparation thereof, compositions, uses, methods of treatment using same and kits6 Aug 2026US 2026/0226020 A1Eurofarma Laboratorios SA
Most cited
By later US patents
- Chemical compounds as inhibitors of amyloid beta protein production110US 5,624,937 AEli Lilly and Company · 1997
- Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals99US 5,658,933 AHoechst Aktiengesellschaft · 1997
- Nitrogen-containing heterocycles75US 4,834,904 AMerck Patent GmbH · 1989
- Inhibitors of p3875US 5,945,418 AVertex Pharmaceuticals Incorporated · 1999
- Muscarinic antagonists74US 5,883,096 ASchering Corporation · 1999